Adam Scott Levy Buys $100K of Mineralys Therapeutics Inc (MLYS) — SEC Form 4, Feb 16, 2023

Open-Market Net Purchase · SEC Form 4
+$100,000

Equity position changed by +1.8%

Reporting Owner
TXN 2023-02-14 · FILED 2023-02-16
Equity Position 351K sh 344,561 → 350,811
Equity Change +1.8% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2023-02-16
Report Date
2023-02-14
Accession No.
0001628280-23-003924
Accepted At
2023-02-16 21:54 UTC
Reporting Owner
Name Relationship
Adam Scott Levy CIK 0001693134
CFO
Adam Scott Levy at Mineralys Therapeutics Inc Full insider history
Bought (12 mo) —
Sold (12 mo) $5,709,439
More from this insider at Mineralys Therapeutics Inc
2026-02-20 Award — View
2026-01-13 Sell -$345,723 View
2025-11-13 Sell -$5,363,716 View
2025-10-15 Sell -$451,984 View
2025-07-31 Sell -$1,077,476 View
All filings by this insider at Mineralys Therapeutics Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common Stock 2023-02-14 P - Purchase 6,250 A $16.00 +$100,000 350,811 Direct
Remarks

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Show more
5%+ Holders · 13D/G 5 filers
Other insiders at Mineralys Therapeutics Inc
All Mineralys Therapeutics Inc insider activity
GET /v1/forms/4/0001628280-23-003924 API docs
View Original SEC Filing